menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Combination Therapy to Manage Lipids

close
Combination Therapy to Manage Lipids
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Despite the wide adoption of statins that are practically in the U.S. drinking water, there are still Americans who are not being treated with lipid-lowering therapies. So what's the answer? Dr. James Stolzenbach, who oversees clinical research in the area of dyslipidemia and renal drug development at Abbott Laboratories, tells the Chicago Tribune's Bruce Japsen about combination therapies and other new drugs being pursued by the pharmaceutical industry to manage cholesterol. 

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Despite the wide adoption of statins that are practically in the U.S. drinking water, there are still Americans who are not being treated with lipid-lowering therapies. So what's the answer? Dr. James Stolzenbach, who oversees clinical research in the area of dyslipidemia and renal drug development at Abbott Laboratories, tells the Chicago Tribune's Bruce Japsen about combination therapies and other new drugs being pursued by the pharmaceutical industry to manage cholesterol. 

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 6/5/20